Report from a Viral Hepatitis Policy Forum on implementing the WHO framework for global action on viral hepatitis in North Asia
Background & Aims The World Health Organisation (WHO) Prevention & Control of Viral Hepatitis Infection: Framework for Global Action offers a global vision for the prevention and control of viral hepatitis. In October 2012, the Coalition to Eradicate Viral Hepatitis in Asia Pacific (CEVHAP)...
Gespeichert in:
Veröffentlicht in: | Journal of hepatology 2013-11, Vol.59 (5), p.1073-1080 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1080 |
---|---|
container_issue | 5 |
container_start_page | 1073 |
container_title | Journal of hepatology |
container_volume | 59 |
creator | Chen, Ding-Shinn Locarnini, Stephen Wait, Suzanne Bae, Si-Hyun Chen, Pei-Jer Fung, James Y.Y Kim, Hong Soo Lu, Sheng-Nan Sung, Joseph Tanaka, Junko Wakita, Takaji Ward, John Wallace, Jack |
description | Background & Aims The World Health Organisation (WHO) Prevention & Control of Viral Hepatitis Infection: Framework for Global Action offers a global vision for the prevention and control of viral hepatitis. In October 2012, the Coalition to Eradicate Viral Hepatitis in Asia Pacific (CEVHAP) organised the North Asia Workshop on Viral Hepatitis in Taipei to discuss how to implement the WHO Framework in the North Asia region. This paper presents outcomes from this workshop. Methods Twenty-eight representatives from local liver associations, patient organisations, and centres of excellence in Hong Kong, Japan, Korea, and Taiwan participated in the workshop. Findings Priority areas for action were described along the four axes of the WHO Framework: (1) awareness, advocacy and resources; (2) evidence and data; (3) prevention of transmission; and (4) screening and treatment. Priorities included: axis 1: greater public and professional awareness, particularly among primary care physicians and local advocacy networks. Axis 2: better economic data and identifying barriers to screening and treatment uptake. Axis 3: monitoring of vaccination outcomes and targeted harm reduction strategies. Axis 4: strengthening links between hospitals and primary care providers, and secure funding of screening and treatment, including for hepatocellular carcinoma. Conclusions The WHO Framework provides an opportunity to develop comprehensive and cohesive policies in North Asia and the broader region. A partnership between clinical specialists, primary care physicians, policy makers, and people with or at risk of viral hepatitis is essential in shaping future policies. |
doi_str_mv | 10.1016/j.jhep.2013.06.029 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1443999752</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0168827813004479</els_id><sourcerecordid>1443999752</sourcerecordid><originalsourceid>FETCH-LOGICAL-c477t-3c66345cc560ae15f43adc15c5e16cc9eb2475d983e13c6650cbcb1a51facf4b3</originalsourceid><addsrcrecordid>eNp9kc1u1DAUhS0EokPhBVggL9kk2LGdHwkhVRXtIFUU8bu0nJubjtMkDnbSala8eh2mdMGikiV78Z1j3e8S8pqzlDOev-vSbodTmjEuUpanLKuekA3PGUtYLvlTsolQmZRZUR6RFyF0jDHBKvmcHGWiVPGVbcifrzg5P9PWu4Ea-tN609MtTma2sw30i-st7OmZ88tA3UjtMPU44Djb8YrOO6S_tpcxawa8df6ats7Tq97VscPAbGMgnpu_nbuHTjvSz_HLHT0J1rwkz1rTB3x1fx-TH2cfv59uk4vL80-nJxcJyKKYEwF5LqQCUDkzyFUrhWmAK1DIc4AK60wWqqlKgXxlFYMaam4Ubw20shbH5O2hd_Lu94Jh1oMNgH1vRnRL0FxKUVVVobKIZgcUvAvBY6snbwfj95ozvYrXnV7F61W8ZrmO4mPozX3_Ug_YPET-mY7A-wOAccobi14HsDgCNtYjzLpx9vH-D__FobejBdNf4x5D5xY_Rn-a65Bppr-tq183zwVjUhaVuAPku6q_</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1443999752</pqid></control><display><type>article</type><title>Report from a Viral Hepatitis Policy Forum on implementing the WHO framework for global action on viral hepatitis in North Asia</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Chen, Ding-Shinn ; Locarnini, Stephen ; Wait, Suzanne ; Bae, Si-Hyun ; Chen, Pei-Jer ; Fung, James Y.Y ; Kim, Hong Soo ; Lu, Sheng-Nan ; Sung, Joseph ; Tanaka, Junko ; Wakita, Takaji ; Ward, John ; Wallace, Jack</creator><creatorcontrib>Chen, Ding-Shinn ; Locarnini, Stephen ; Wait, Suzanne ; Bae, Si-Hyun ; Chen, Pei-Jer ; Fung, James Y.Y ; Kim, Hong Soo ; Lu, Sheng-Nan ; Sung, Joseph ; Tanaka, Junko ; Wakita, Takaji ; Ward, John ; Wallace, Jack ; CEVHAP North Asia Workshop on Viral Hepatitis</creatorcontrib><description>Background & Aims The World Health Organisation (WHO) Prevention & Control of Viral Hepatitis Infection: Framework for Global Action offers a global vision for the prevention and control of viral hepatitis. In October 2012, the Coalition to Eradicate Viral Hepatitis in Asia Pacific (CEVHAP) organised the North Asia Workshop on Viral Hepatitis in Taipei to discuss how to implement the WHO Framework in the North Asia region. This paper presents outcomes from this workshop. Methods Twenty-eight representatives from local liver associations, patient organisations, and centres of excellence in Hong Kong, Japan, Korea, and Taiwan participated in the workshop. Findings Priority areas for action were described along the four axes of the WHO Framework: (1) awareness, advocacy and resources; (2) evidence and data; (3) prevention of transmission; and (4) screening and treatment. Priorities included: axis 1: greater public and professional awareness, particularly among primary care physicians and local advocacy networks. Axis 2: better economic data and identifying barriers to screening and treatment uptake. Axis 3: monitoring of vaccination outcomes and targeted harm reduction strategies. Axis 4: strengthening links between hospitals and primary care providers, and secure funding of screening and treatment, including for hepatocellular carcinoma. Conclusions The WHO Framework provides an opportunity to develop comprehensive and cohesive policies in North Asia and the broader region. A partnership between clinical specialists, primary care physicians, policy makers, and people with or at risk of viral hepatitis is essential in shaping future policies.</description><identifier>ISSN: 0168-8278</identifier><identifier>EISSN: 1600-0641</identifier><identifier>DOI: 10.1016/j.jhep.2013.06.029</identifier><identifier>PMID: 23850942</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Antiviral Agents - therapeutic use ; Asia ; Asia, Northern - epidemiology ; Gastroenterology and Hepatology ; Hepatitis B ; Hepatitis C ; Hepatitis, Viral, Human - drug therapy ; Hepatitis, Viral, Human - epidemiology ; Hepatitis, Viral, Human - prevention & control ; Humans ; Policy ; Policy Making ; Risk Factors ; Viral Vaccines - therapeutic use ; World Health Organization</subject><ispartof>Journal of hepatology, 2013-11, Vol.59 (5), p.1073-1080</ispartof><rights>European Association for the Study of the Liver</rights><rights>2013 European Association for the Study of the Liver</rights><rights>Copyright © 2013 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c477t-3c66345cc560ae15f43adc15c5e16cc9eb2475d983e13c6650cbcb1a51facf4b3</citedby><cites>FETCH-LOGICAL-c477t-3c66345cc560ae15f43adc15c5e16cc9eb2475d983e13c6650cbcb1a51facf4b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0168827813004479$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>309,310,314,776,780,785,786,3537,23911,23912,25120,27903,27904,65309</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23850942$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chen, Ding-Shinn</creatorcontrib><creatorcontrib>Locarnini, Stephen</creatorcontrib><creatorcontrib>Wait, Suzanne</creatorcontrib><creatorcontrib>Bae, Si-Hyun</creatorcontrib><creatorcontrib>Chen, Pei-Jer</creatorcontrib><creatorcontrib>Fung, James Y.Y</creatorcontrib><creatorcontrib>Kim, Hong Soo</creatorcontrib><creatorcontrib>Lu, Sheng-Nan</creatorcontrib><creatorcontrib>Sung, Joseph</creatorcontrib><creatorcontrib>Tanaka, Junko</creatorcontrib><creatorcontrib>Wakita, Takaji</creatorcontrib><creatorcontrib>Ward, John</creatorcontrib><creatorcontrib>Wallace, Jack</creatorcontrib><creatorcontrib>CEVHAP North Asia Workshop on Viral Hepatitis</creatorcontrib><title>Report from a Viral Hepatitis Policy Forum on implementing the WHO framework for global action on viral hepatitis in North Asia</title><title>Journal of hepatology</title><addtitle>J Hepatol</addtitle><description>Background & Aims The World Health Organisation (WHO) Prevention & Control of Viral Hepatitis Infection: Framework for Global Action offers a global vision for the prevention and control of viral hepatitis. In October 2012, the Coalition to Eradicate Viral Hepatitis in Asia Pacific (CEVHAP) organised the North Asia Workshop on Viral Hepatitis in Taipei to discuss how to implement the WHO Framework in the North Asia region. This paper presents outcomes from this workshop. Methods Twenty-eight representatives from local liver associations, patient organisations, and centres of excellence in Hong Kong, Japan, Korea, and Taiwan participated in the workshop. Findings Priority areas for action were described along the four axes of the WHO Framework: (1) awareness, advocacy and resources; (2) evidence and data; (3) prevention of transmission; and (4) screening and treatment. Priorities included: axis 1: greater public and professional awareness, particularly among primary care physicians and local advocacy networks. Axis 2: better economic data and identifying barriers to screening and treatment uptake. Axis 3: monitoring of vaccination outcomes and targeted harm reduction strategies. Axis 4: strengthening links between hospitals and primary care providers, and secure funding of screening and treatment, including for hepatocellular carcinoma. Conclusions The WHO Framework provides an opportunity to develop comprehensive and cohesive policies in North Asia and the broader region. A partnership between clinical specialists, primary care physicians, policy makers, and people with or at risk of viral hepatitis is essential in shaping future policies.</description><subject>Antiviral Agents - therapeutic use</subject><subject>Asia</subject><subject>Asia, Northern - epidemiology</subject><subject>Gastroenterology and Hepatology</subject><subject>Hepatitis B</subject><subject>Hepatitis C</subject><subject>Hepatitis, Viral, Human - drug therapy</subject><subject>Hepatitis, Viral, Human - epidemiology</subject><subject>Hepatitis, Viral, Human - prevention & control</subject><subject>Humans</subject><subject>Policy</subject><subject>Policy Making</subject><subject>Risk Factors</subject><subject>Viral Vaccines - therapeutic use</subject><subject>World Health Organization</subject><issn>0168-8278</issn><issn>1600-0641</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kc1u1DAUhS0EokPhBVggL9kk2LGdHwkhVRXtIFUU8bu0nJubjtMkDnbSala8eh2mdMGikiV78Z1j3e8S8pqzlDOev-vSbodTmjEuUpanLKuekA3PGUtYLvlTsolQmZRZUR6RFyF0jDHBKvmcHGWiVPGVbcifrzg5P9PWu4Ea-tN609MtTma2sw30i-st7OmZ88tA3UjtMPU44Djb8YrOO6S_tpcxawa8df6ats7Tq97VscPAbGMgnpu_nbuHTjvSz_HLHT0J1rwkz1rTB3x1fx-TH2cfv59uk4vL80-nJxcJyKKYEwF5LqQCUDkzyFUrhWmAK1DIc4AK60wWqqlKgXxlFYMaam4Ubw20shbH5O2hd_Lu94Jh1oMNgH1vRnRL0FxKUVVVobKIZgcUvAvBY6snbwfj95ozvYrXnV7F61W8ZrmO4mPozX3_Ug_YPET-mY7A-wOAccobi14HsDgCNtYjzLpx9vH-D__FobejBdNf4x5D5xY_Rn-a65Bppr-tq183zwVjUhaVuAPku6q_</recordid><startdate>20131101</startdate><enddate>20131101</enddate><creator>Chen, Ding-Shinn</creator><creator>Locarnini, Stephen</creator><creator>Wait, Suzanne</creator><creator>Bae, Si-Hyun</creator><creator>Chen, Pei-Jer</creator><creator>Fung, James Y.Y</creator><creator>Kim, Hong Soo</creator><creator>Lu, Sheng-Nan</creator><creator>Sung, Joseph</creator><creator>Tanaka, Junko</creator><creator>Wakita, Takaji</creator><creator>Ward, John</creator><creator>Wallace, Jack</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20131101</creationdate><title>Report from a Viral Hepatitis Policy Forum on implementing the WHO framework for global action on viral hepatitis in North Asia</title><author>Chen, Ding-Shinn ; Locarnini, Stephen ; Wait, Suzanne ; Bae, Si-Hyun ; Chen, Pei-Jer ; Fung, James Y.Y ; Kim, Hong Soo ; Lu, Sheng-Nan ; Sung, Joseph ; Tanaka, Junko ; Wakita, Takaji ; Ward, John ; Wallace, Jack</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c477t-3c66345cc560ae15f43adc15c5e16cc9eb2475d983e13c6650cbcb1a51facf4b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Antiviral Agents - therapeutic use</topic><topic>Asia</topic><topic>Asia, Northern - epidemiology</topic><topic>Gastroenterology and Hepatology</topic><topic>Hepatitis B</topic><topic>Hepatitis C</topic><topic>Hepatitis, Viral, Human - drug therapy</topic><topic>Hepatitis, Viral, Human - epidemiology</topic><topic>Hepatitis, Viral, Human - prevention & control</topic><topic>Humans</topic><topic>Policy</topic><topic>Policy Making</topic><topic>Risk Factors</topic><topic>Viral Vaccines - therapeutic use</topic><topic>World Health Organization</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chen, Ding-Shinn</creatorcontrib><creatorcontrib>Locarnini, Stephen</creatorcontrib><creatorcontrib>Wait, Suzanne</creatorcontrib><creatorcontrib>Bae, Si-Hyun</creatorcontrib><creatorcontrib>Chen, Pei-Jer</creatorcontrib><creatorcontrib>Fung, James Y.Y</creatorcontrib><creatorcontrib>Kim, Hong Soo</creatorcontrib><creatorcontrib>Lu, Sheng-Nan</creatorcontrib><creatorcontrib>Sung, Joseph</creatorcontrib><creatorcontrib>Tanaka, Junko</creatorcontrib><creatorcontrib>Wakita, Takaji</creatorcontrib><creatorcontrib>Ward, John</creatorcontrib><creatorcontrib>Wallace, Jack</creatorcontrib><creatorcontrib>CEVHAP North Asia Workshop on Viral Hepatitis</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of hepatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chen, Ding-Shinn</au><au>Locarnini, Stephen</au><au>Wait, Suzanne</au><au>Bae, Si-Hyun</au><au>Chen, Pei-Jer</au><au>Fung, James Y.Y</au><au>Kim, Hong Soo</au><au>Lu, Sheng-Nan</au><au>Sung, Joseph</au><au>Tanaka, Junko</au><au>Wakita, Takaji</au><au>Ward, John</au><au>Wallace, Jack</au><aucorp>CEVHAP North Asia Workshop on Viral Hepatitis</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Report from a Viral Hepatitis Policy Forum on implementing the WHO framework for global action on viral hepatitis in North Asia</atitle><jtitle>Journal of hepatology</jtitle><addtitle>J Hepatol</addtitle><date>2013-11-01</date><risdate>2013</risdate><volume>59</volume><issue>5</issue><spage>1073</spage><epage>1080</epage><pages>1073-1080</pages><issn>0168-8278</issn><eissn>1600-0641</eissn><abstract>Background & Aims The World Health Organisation (WHO) Prevention & Control of Viral Hepatitis Infection: Framework for Global Action offers a global vision for the prevention and control of viral hepatitis. In October 2012, the Coalition to Eradicate Viral Hepatitis in Asia Pacific (CEVHAP) organised the North Asia Workshop on Viral Hepatitis in Taipei to discuss how to implement the WHO Framework in the North Asia region. This paper presents outcomes from this workshop. Methods Twenty-eight representatives from local liver associations, patient organisations, and centres of excellence in Hong Kong, Japan, Korea, and Taiwan participated in the workshop. Findings Priority areas for action were described along the four axes of the WHO Framework: (1) awareness, advocacy and resources; (2) evidence and data; (3) prevention of transmission; and (4) screening and treatment. Priorities included: axis 1: greater public and professional awareness, particularly among primary care physicians and local advocacy networks. Axis 2: better economic data and identifying barriers to screening and treatment uptake. Axis 3: monitoring of vaccination outcomes and targeted harm reduction strategies. Axis 4: strengthening links between hospitals and primary care providers, and secure funding of screening and treatment, including for hepatocellular carcinoma. Conclusions The WHO Framework provides an opportunity to develop comprehensive and cohesive policies in North Asia and the broader region. A partnership between clinical specialists, primary care physicians, policy makers, and people with or at risk of viral hepatitis is essential in shaping future policies.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>23850942</pmid><doi>10.1016/j.jhep.2013.06.029</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0168-8278 |
ispartof | Journal of hepatology, 2013-11, Vol.59 (5), p.1073-1080 |
issn | 0168-8278 1600-0641 |
language | eng |
recordid | cdi_proquest_miscellaneous_1443999752 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Antiviral Agents - therapeutic use Asia Asia, Northern - epidemiology Gastroenterology and Hepatology Hepatitis B Hepatitis C Hepatitis, Viral, Human - drug therapy Hepatitis, Viral, Human - epidemiology Hepatitis, Viral, Human - prevention & control Humans Policy Policy Making Risk Factors Viral Vaccines - therapeutic use World Health Organization |
title | Report from a Viral Hepatitis Policy Forum on implementing the WHO framework for global action on viral hepatitis in North Asia |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T03%3A03%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Report%20from%20a%20Viral%20Hepatitis%20Policy%20Forum%20on%20implementing%20the%20WHO%20framework%20for%20global%20action%20on%20viral%20hepatitis%20in%20North%20Asia&rft.jtitle=Journal%20of%20hepatology&rft.au=Chen,%20Ding-Shinn&rft.aucorp=CEVHAP%20North%20Asia%20Workshop%20on%20Viral%20Hepatitis&rft.date=2013-11-01&rft.volume=59&rft.issue=5&rft.spage=1073&rft.epage=1080&rft.pages=1073-1080&rft.issn=0168-8278&rft.eissn=1600-0641&rft_id=info:doi/10.1016/j.jhep.2013.06.029&rft_dat=%3Cproquest_cross%3E1443999752%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1443999752&rft_id=info:pmid/23850942&rft_els_id=S0168827813004479&rfr_iscdi=true |